Abstract
Neisseria meningitidis(meningococcus) causes invasive diseases such as meningitis or septicaemia.Ex vivoinfection of human whole blood is a valuable tool to study meningococcal virulence factors and the host innate immune responses. In order to consider effects of cellular mediators, the coagulation cascade must be inhibited to avoid clotting. There is considerable variation in the anticoagulants used among studies ofN.meningitidiswhole blood infections, featuring citrate, heparin or derivatives of hirudin, a polypeptide from leech saliva. Here, we compare the influence of these three different anticoagulants, and additionally Mg/EGTA, on host innate immune responses as well as on viability ofN.meningitidisstrains isolated from healthy carriers and disease cases, reflecting different sequence types and capsule phenotypes. We found that the anticoagulants significantly impact on cellular responses and, strain-dependently, also on bacterial survival. Hirudin does not inhibit complement and is therefore superior over the other anticoagulants; indeed hirudin-plasma most closely reflects the characteristics of serum duringN.meningitidisinfection. We further demonstrate the impact of heparin on complement activation onN.meningitidisand its consequences on meningococcal survival in immune sera, which appears to be independent of the heparin binding antigens Opc and NHBA.
Funding Information
  • Deutsche Forschungsgemeinschaft (JO 1204/2-1)

This publication has 60 references indexed in Scilit: